Breaking News Instant updates and real-time market news.

SSYS

Stratasys

$30.66

0.73 (2.44%)

07:41
05/17/17
05/17
07:41
05/17/17
07:41

Stratasys downgraded to Hold from Buy at Needham

Needham analyst James Ricchiuti downgraded Stratasys to Hold from Buy citing the recent "sharp" rise in the shares despite only a "modest" improvement in the company's fundamentals. While Stratasys could see stronger growth next year, the timing of additive manufacturing deployments is uncertain and the general purpose prototyping business is becoming an increasingly mature market, Ricchiuti tells investors.

  • 17

    May

  • 30

    May

SSYS Stratasys
$30.66

0.73 (2.44%)

05/12/17
STPT
05/12/17
DOWNGRADE
STPT
Hold
Stratasys downgraded to Hold from Reduce at Standpoint Research
Standpoint Research analyst Ronnie Moas downgraded Stratasys another notch lower today, to Hold from Reduce, after previously having cut the stock to Reduce from a Buy on April 24. Noting that stock has doubled off its 52-week low, Moas said he can no longer leave a bullish rating on the shares, citing valuation.
05/15/17
WBLR
05/15/17
DOWNGRADE
WBLR
Underperform
Stratasys downgraded to Underperform from Market Perform at William Blair
William Blair analyst Brian Drab downgraded Stratasys to Underperform.
05/15/17
WBLR
05/15/17
DOWNGRADE
WBLR
Underperform
William Blair calls Stratasys overvalued, downgrades to Underperform
William Blair analyst Brian Drab downgraded Stratasys to Underperform from Market Perform with the shares up 43% in the last month and 81% year-to-date. The stock is overvalued at $30, Drab tells investors in a research note. This price represents a 100 times multiple on the consensus 2017 adjusted earnings estimate and 57 times multiple on the 2018 consensus estimate, the analyst points out. He says the current valuation "reflects expectations for a return to robust growth and material margin expansion, both of which are unlikely."
05/16/17
PIPR
05/16/17
NO CHANGE
Target $38
PIPR
Overweight
Piper says Stratasys should be able to beat 'overly conservative' guidance
Piper Jaffray analyst Troy Jensen noted that Stratasys reiterated 2017 guidance for sales to decline 2%, but he argues that this "overly conservative" estimate is inconsistent with the feedback he is getting from Stratasys' resellers pointing to stronger system demand trends. The analyst, who expects Stratasys will be able to exceed expectations throughout the year, raised his price target on the stock to $38 from $28 and reiterates an Overweight rating on the name.

TODAY'S FREE FLY STORIES

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

, UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Recommendations
Exact Sciences, UnitedHealth analyst commentary  »

Exact Sciences remains a…

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 06

    Jun

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

, NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 09

    Jun

FRO

Frontline

$5.41

-0.22 (-3.91%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Upgrade
Frontline rating change  »

Frontline upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGHT

8x8, Inc.

$13.60

0.1 (0.74%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Conference/Events
8x8, Inc. management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 06

    Jun

  • 08

    Jun

  • 13

    Jun

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

, FRO

Frontline

$5.41

-0.22 (-3.91%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Recommendations
Gener8 Maritime, Frontline, DHT Holdings analyst commentary  »

Gener8 Maritime advance…

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

FRO

Frontline

$5.41

-0.22 (-3.91%)

DHT

DHT Holdings

$4.20

-0.07 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

, ORCL

Oracle

$45.42

0.16 (0.35%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

ORCL

Oracle

$45.42

0.16 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:25
05/31/17
05/31
07:25
05/31/17
07:25
Technical Analysis
Technical View: Michael Kors drops to new 52-week low after earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CBS

CBS

$61.52

-0.05 (-0.08%)

, CBS.A

$63.50

-0.15 (-0.24%)

07:24
05/31/17
05/31
07:24
05/31/17
07:24
Periodicals
Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says »

CBS (CBS, CBS.A) news…

CBS

CBS

$61.52

-0.05 (-0.08%)

CBS.A

$63.50

-0.15 (-0.24%)

CMCSA

Comcast

$41.10

0.19 (0.46%)

CMCSK

Comcast

DIS

Disney

$108.34

-0.07 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 08

    Jun

  • 15

    Jun

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors drops 7% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

UAA

Under Armour

$19.56

-0.13 (-0.66%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Recommendations
Under Armour analyst commentary  »

Under Armour has reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

07:22
05/31/17
05/31
07:22
05/31/17
07:22
General news
Futures higher ahead of final trading for May »

Stock futures are above…

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:22
05/31/17
05/31
07:22
05/31/17
07:22
Hot Stocks
Michael Kors says to close 100-125 full-price retail stores over next two years »

Michael Kors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MYL

Mylan

$39.36

-0.36 (-0.91%)

07:19
05/31/17
05/31
07:19
05/31/17
07:19
Recommendations
Mylan analyst commentary  »

Pension fund campaign a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 09

    Oct

VIAB

Viacom

$35.05

-0.08 (-0.23%)

, VIA

Viacom

$38.90

0.5 (1.30%)

07:17
05/31/17
05/31
07:17
05/31/17
07:17
Recommendations
Viacom, Viacom analyst commentary  »

Viacom price target…

VIAB

Viacom

$35.05

-0.08 (-0.23%)

VIA

Viacom

$38.90

0.5 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$1.37

-0.02 (-1.44%)

07:17
05/31/17
05/31
07:17
05/31/17
07:17
Hot Stocks
22nd Century reports 'dramatic surge' in VLN tobacco clinical trials, science »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$45.00

0.29 (0.65%)

07:16
05/31/17
05/31
07:16
05/31/17
07:16
Recommendations
Abbott analyst commentary  »

Abbott making progress, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRMN

Garmin

$52.11

-0.29 (-0.55%)

07:15
05/31/17
05/31
07:15
05/31/17
07:15
Hot Stocks
Garmin launches Approach S60 golf watch »

Garmin International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCA

U.S. Silica

$36.45

-0.76 (-2.04%)

07:15
05/31/17
05/31
07:15
05/31/17
07:15
Technical Analysis
Technical View: U.S. Silica trades higher in pre-market »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GPRK

GeoPark

$8.71

-0.18 (-2.02%)

07:12
05/31/17
05/31
07:12
05/31/17
07:12
Hot Stocks
GeoPark names Coulter Enterprises Chairman and CEO Coulter to board »

GeoPark Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$4.70

-0.3 (-6.00%)

07:12
05/31/17
05/31
07:12
05/31/17
07:12
Hot Stocks
ProQR Therapeutics' QR-110 granted Fast Track designation by FDA »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$66.30

-0.57 (-0.85%)

07:11
05/31/17
05/31
07:11
05/31/17
07:11
Downgrade
Molina Healthcare rating change  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$43.41

0.74 (1.73%)

07:11
05/31/17
05/31
07:11
05/31/17
07:11
Technical Analysis
Technical View: GlaxoSmithKline rises in early trading »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

RGNX

Regenxbio

$16.70

-1.3 (-7.22%)

07:09
05/31/17
05/31
07:09
05/31/17
07:09
Earnings
Regenxbio initiates Phase 1 clinical trial of RGX-314 for macular degeneration »

Regenxbio has dosed the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$130.49

-3.89 (-2.89%)

07:08
05/31/17
05/31
07:08
05/31/17
07:08
Recommendations
Incyte analyst commentary  »

Incyte price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 13

    Jun

  • 15

    Jun

TRIL

Trillium Therapeutics

$5.05

0.05 (1.00%)

07:08
05/31/17
05/31
07:08
05/31/17
07:08
Hot Stocks
Trillium to present TTI-621 immune checkpoint inhibitor program at ASCO »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.